An AI platform for analyzing complex medical data
Official title: ISYSMET: AI-POWERED PLATFORM FOR INTEGRATIVE ANALYSIS OFMULTIMODAL DATA
Funded at Omicscraft, LLC · NIH-11196862 · Data updated 2026-11-12
This study is creating a smart online tool that looks at different types of medical information, like images and genetic data, to help doctors understand cancer better and find new ways to treat it, which could really help patients like you.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Omicscraft, LLC NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project start | September 16, 2024 |
| Project end | September 15, 2026 |
| Funding year | 2024 |
| Award (this year) | $2,000,000 |
| NIH project number | 75N91024C00093-0-9999-1 |
| Project ID | NIH-11196862 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include patients diagnosed with cancer who have undergone imaging and multi-omics testing.
✕Less likely to help
Patients with non-cancerous conditions or those who have not undergone relevant imaging or multi-omics testing may not benefit from this research.
What this research studies
This research aims to develop an innovative AI-powered platform that integrates and analyzes complex medical data, including imaging and multi-omics information. By leveraging cloud-based resources, the project seeks to overcome computational challenges associated with large-scale data from sources like The Cancer Genome Atlas and The Cancer Imaging Archive. Patients can benefit from this research as it aims to uncover relationships between medical images, molecular events, and clinical outcomes, potentially leading to improved cancer treatment strategies.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments by revealing critical insights from complex medical data.
How similar studies have gone: Other research has shown success in utilizing AI and cloud-based platforms for data analysis in cancer research, indicating a promising approach.
Where this research is happening
-
Omicscraft, LLC
Washington, United States Active
Researchers
- Principal investigator: Ressom, Tom — Omicscraft, LLC
- Study coordinator: Ressom, Tom
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.